Predicting survival in patients with advanced cancer in the last weeks of life: How accurate are prognostic models compared to clinicians' estimates?

被引:32
|
作者
Hui, David [1 ,2 ]
Ross, Jeremy [3 ]
Park, Minjeong [4 ]
Dev, Rony [1 ]
Vidal, Marieberta [1 ]
Liu, Diane [4 ]
Paiva, Carlos Eduardo [5 ]
Bruera, Eduardo [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care Rehabil & Integrat Med, Unit 1414,1515 Holcombe Blvd, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Gen Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Barretos Canc Hosp, Dept Clin Oncol, Barretos, Brazil
基金
美国国家卫生研究院;
关键词
Palliative medicine; palliative care; prognosis; terminal care; survival analysis; PALLIATIVE CARE; PERFORMANCE STATUS; IMPENDING DEATH; INDEX; SCORE; VALIDATION; DELIRIUM; TIME;
D O I
10.1177/0269216319873261
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: It is unclear if validated prognostic scores such as the Palliative Performance Scale, Palliative Prognostic Index, and Palliative Prognostic Score are more accurate than clinician prediction of survival in patients admitted to an acute palliative care unit with only days of survival. Aim: We compared the prognostic accuracy of Palliative Performance Scale, Palliative Prognostic Index, Palliative Prognostic Score, and clinician prediction of survival in this setting. Design: This is a pre-planned secondary analysis of a prospective study. Setting/participants: We assessed Palliative Performance Scale, Palliative Prognostic Index, Palliative Prognostic Score, and clinician prediction of survival at baseline. We computed their prognostic accuracy using the Concordance index and area under the receiver operating characteristics curve for 7-, 14-, and 30-day survival. Results: A total of 204 patients were included with a median overall survival of 10 days (95% confidence interval: 8-11 days). The Concordance index for Palliative Performance Scale, Palliative Prognostic Index, Palliative Prognostic Score, and clinician prediction of survival were 0.74, 0.71, 0.70, and 0.75, respectively. The areas under the curve for these approaches were 0.82-0.87 for 30-day survival, 0.75-0.80 for 14-day survival, and 0.74-0.81 for 7-day survival. The four prognostic approaches had similar accuracies, with the exception of 7-day survival in which clinician prediction of survival was significantly more accurate than Palliative Prognostic Score (difference: 7%) and Palliative Prognostic Index (difference: 8%). Conclusion: In patients with advanced cancer with days of survival, clinician prediction of survival and Palliative Performance Scale alone were as accurate as Palliative Prognostic Score and Palliative Prognostic Index. These four approaches may be useful for prognostication in acute palliative care units. Our findings highlight how patient population may impact the accuracy of prognostic scores.
引用
收藏
页码:126 / 133
页数:8
相关论文
共 30 条
  • [21] "Don't let the world become too small" - How patients with advanced cancer and their significant others cope with transitions during the last year of life. A qualitative study
    Chabloz-Sussenbach, Christiane
    Schramm, Monique Sailer
    Stoll, Hansruedi
    Spirig, Rebecca
    PFLEGE, 2016, 29 (04): : 171 - 181
  • [22] Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs
    Du, Xinyang
    Bai, Hua
    Wang, Zhijie
    Daun, Jianchun
    Liu, Zheng
    Xu, Jiachen
    Chang, Geyun
    Zhu, Yixiang
    Wang, Jie
    THORACIC CANCER, 2022, 13 (09) : 1289 - 1298
  • [23] Development of prognostic model for predicting survival after retrograde placement of ureteral stent in advanced gastrointestinal cancer patients and its evaluation by decision curve analysis
    Kawano, Shingo
    Komai, Yoshinobu
    Ishioka, Junichiro
    Sakai, Yasuyuki
    Fuse, Nozomu
    Ito, Masaaki
    Kihara, Kazunori
    Saito, Norio
    MINERVA UROLOGICA E NEFROLOGICA, 2016, 68 (05) : 437 - 443
  • [24] PROGNOSTIC SIGNIFICANCE, ACCURACY AND USEFULNESS OF ONCOLOGISTS` ESTIMATES OF SURVIVAL TIME FOR PATIENTS STARTING FIRST-LINE CHEMOTHERAPY FOR ADVANCED NON-SMALL-CELL LUNG CANCER (ANSCLC)
    Kiely, Belinda E.
    Veillard, Anne-Sophie
    Davidson, John A.
    Trinkaus, Mateya E.
    Briscoe, Karen P.
    Hughes, Brett
    Begbie, Stephen
    Pavlakis, Nick
    Millward, Michael
    Boyer, Michael
    Brown, Chris
    Muljadi, Nick
    Coskinas, Xanthi
    Stockler, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S880 - S880
  • [25] The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer
    Guo, Shuai
    Shang, Muyan
    Dong, Zhe
    Zhang, Jun
    Wang, Yue
    Zhao, Yan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (02) : E117 - E124
  • [26] A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy
    Fanhao Kong
    Honglan Yang
    Qiaoxia Wang
    Zhigang Wei
    Xin Ye
    European Radiology, 2023, 33 : 7438 - 7449
  • [27] A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy
    Kong, Fanhao
    Yang, Honglan
    Wang, Qiaoxia
    Wei, Zhigang
    Ye, Xin
    EUROPEAN RADIOLOGY, 2023, 33 (11) : 7438 - 7449
  • [28] C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer
    Fujiwara, Yuki
    Haruki, Koichiro
    Shiba, Hiroaki
    Hamura, Ryoga
    Horiuchi, Takashi
    Shirai, Yoshihiro
    Furukawa, Kenei
    Gocho, Takeshi
    Yanaga, Katsuhiko
    ANTICANCER RESEARCH, 2018, 38 (11) : 6491 - 6499
  • [29] Prognostic effects of health-related quality of life at baseline and early change in health-related quality of life on response to treatment and survival in patients with advanced lung cancer: a prospective observational study in China
    Liu, Jiali
    Ma, Yuxiang
    Gao, Ruizhen
    Liu, Xia
    Wang, Yalan
    Yu, Juan
    Zhan, Jianhua
    Huang, Yan
    Qin, Huiyin
    Zhang, Li
    BMJ OPEN, 2022, 12 (02):
  • [30] Pretreatment Prognostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Vascular, Texture, Shape, and Size Parameters Compared With Traditional Survival Indicators Obtained From Locally Advanced Breast Cancer Patients
    Pickles, Martin D.
    Lowry, Martin
    Gibbs, Peter
    INVESTIGATIVE RADIOLOGY, 2016, 51 (03) : 177 - 185